arrow
T

Talat Aykut

Necmettin Erbakan University
H指数:2
被引数:14

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer

更正:吉西他滨联合nab-紫杉醇在转移性胰腺癌二线治疗中的疗效

2026-04-030
OAAI
Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG)

比较一线FOLFIRINOX与基于氟尿嘧啶和基于吉西他滨的化疗在转移性壶腹腺癌中的疗效:一项由土耳其肿瘤学组(TOG)进行的多中心研究

2025-08-230
PRE
FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG)

FOLFIRINOX:胰腺导管腺癌的最佳辅助治疗?土耳其肿瘤学组(TOG)的多中心研究

2025-08-220
PRE
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer

吉西他滨联合白蛋白结合型紫杉醇二线治疗转移性胰腺癌的疗效观察

2025-04-050
OAAI
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study

细胞周期蛋白依赖性激酶抑制剂后依维莫司加激素治疗的疗效; 现实生活经验,TOG研究

2024-08-090
PRE